Superworth908 Devices EPS MASS
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$0.93
- Latest quarter, Q2 FY26
- −$0.32
- Fiscal year 2025
- $0.57
908 Devices' earnings per share was −$0.93 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.32.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.57 | n/a |
| FY2024 | −$2.10 | n/a |
| FY2023 | −$1.13 | n/a |
| FY2022 | −$1.07 | n/a |
| FY2021 | −$0.80 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.32 | n/a | −$0.93 | |
| Q1 FY26 | −$0.32 | −126% | −$0.98 | |
| Q4 FY25 | $0.12 | n/a | $0.57 | |
| Q3 FY25 | −$0.41 | n/a | −$0.11 | |
| Q2 FY25 | −$0.37 | n/a | −$0.54 | |
| Q1 FY25 | $1.23 | n/a | −$0.54 | |
| Q4 FY24 | −$0.56 | n/a | −$2.10 | |
| Q3 FY24 | −$0.84 | n/a | −$1.77 | |
| Q2 FY24 | −$0.37 | n/a | −$1.15 | |
| Q1 FY24 | −$0.33 | n/a | −$1.07 | |
| Q4 FY23 | −$0.23 | n/a | −$1.13 | |
| Q3 FY23 | −$0.22 | n/a | −$1.21 |
Against its peers
Companies in Medical - Diagnostics & Research nearest 908 Devices' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MASS908 Devices | −$0.93 | |
| NRCNRC Health | $0.25 | −67% a year |
| ICCCImmucell | $0.08 | −58% a year |
| CDNACareDx | $2.07 | +116% a year |
| VCYTVeracyte | $1.40 | +324% a year |
| Peer median | $0.82 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on 908 Devices
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.